Inulin
Natural health product licensed in Canada
- Other names
- Equate Inulin Fibre, Exact Inulin Fibre, Life Brand Clearly Fibre, miNaturals Inulin Fibre, miNaturals Inulin Fibre- Strawberry Kiwi, miNaturals inulin fibre- Orange
- Licence holder
- Direct NutriSciences Inc.
- NPN or DIN-HM
- 80047322
- Status
- Active licence
- Licence date
- 17 December 2013
- Revision date
- 15 March 2022
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Saveur d'orange, Extrait de Stevia rebaudiana, Saveur fraise kiwi, DL-Tartaric acid, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 2.5 g ; maximum: 5 g | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Source of fiber for the maintenance of good health. Helps support and maintain a healthy digestive system. Helps stimulate the growth of healthy bacteria (such as bifidobateria) in the intestine/gut. Prebiotic. Helps provide gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity has been known to occur. Products providing more than 5 g per day: May cause mild gastro-intestinal discomfort (such as gas, bloating, cramps).
- Précautions et mises en garde
If symptoms worsen or if laxative effect does not occur within seven days, consult a health care practitioner. If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use (e.g. opioids, loperamide). If you have symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use. If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80047322
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.